# Orphenadrine Citrate

NDC: 0185-0022
Generic name: Orphenadrine Citrate
Labeler / Manufacturer: Sandoz Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20000215
Marketing ended: 20270320
FDA application: ANDA040327

## Active ingredients

- ORPHENADRINE CITRATE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0185-0022"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0185-0022
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=239018ff-cec6-46de-ae9d-26c9ec034a32